{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T01:10:33Z","timestamp":1777425033263,"version":"3.51.4"},"reference-count":36,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1016\/j.jhep.2005.02.032","type":"journal-article","created":{"date-parts":[[2005,5,6]],"date-time":"2005-05-06T22:48:52Z","timestamp":1115419732000},"page":"653-660","source":"Crossref","is-referenced-by-count":33,"title":["Celecoxib, a cyclooxygenase-2 inhibitor, prevents induction of liver preneoplastic lesions in rats"],"prefix":"10.1016","volume":"43","author":[{"given":"Lucrecia","family":"M\u00e1rquez-Rosado","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Cristina","family":"Trejo-Sol\u00eds","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia Mar\u00eda","family":"Garc\u00eda-Cu\u00e9llar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sa\u00fal","family":"Villa-Trevi\u00f1o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2005.02.032_bib1","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/272634a0","article-title":"Ehnancement of carcinogenesis by prostaglandins","volume":"272","author":"Lupulesco","year":"1978","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2005.02.032_bib2","first-page":"M69","article-title":"Cyclooxygenase-2 and carcinogenesis","volume":"1470","author":"Prescott","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jhep.2005.02.032_bib3","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s004320000225","article-title":"Cyclooxygenase-2: a novel target for cancer chemotherapy?","volume":"127","author":"Dempke","year":"2001","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.jhep.2005.02.032_bib4","first-page":"409","article-title":"Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis","volume":"58","author":"Kawamori","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.jhep.2005.02.032_bib5","first-page":"5599","article-title":"Celecoxib inhibits N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancers in male B6D2F1 mice and female fisher-344 rats","volume":"60","author":"Grubbs","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.jhep.2005.02.032_bib6","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1093\/carcin\/20.10.1939","article-title":"Reduction of UV-induced skin tumors in hairless mice by selective COX-2 inhibition","volume":"10","author":"Pentland","year":"1999","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.jhep.2005.02.032_bib7","first-page":"2101","article-title":"Chemoprevention of breast cancer in rats by celecoxib a cyclooxygenase 2 inhibitor","volume":"60","author":"Harris","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.jhep.2005.02.032_bib8","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1056\/NEJM200006293422603","article-title":"The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis","volume":"342","author":"Steinbach","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2005.02.032_bib9","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1053\/jhep.2002.36125","article-title":"Proapoptotic and antiproliferative potential of selective cyclooxygenase-2 inhibitors in human liver tumor cells","volume":"36","author":"Kern","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2005.02.032_bib10","first-page":"1306","article-title":"Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors","volume":"60","author":"Masferrer","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.jhep.2005.02.032_bib11","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.bcp.2003.12.014","article-title":"Cyclooxygenase-2 (COX-2)-dependent and -independent anticarcinogenic effects of celecoxib in human colon carcinoma cells","volume":"67","author":"Maier","year":"2004","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jhep.2005.02.032_bib12","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1158\/0008-5472.CAN-03-1086","article-title":"Cyclooxygenase-2 promotes human cholangiocarcinoma growth: evidence for cyclooxygenase-2-independent mechanism in celecoxib-mediated induction of p21waf1\/cip1 and p27kip1 and cell cycle arrest","volume":"64","author":"Han","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.jhep.2005.02.032_bib13","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/sj.onc.1206234","article-title":"Suppression of RelA\/p65 nuclear translocation independent of IkappaB-alpha degradation by cyclooxygenase-2 inhibitor in gastric cancer","volume":"22","author":"Wong","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.jhep.2005.02.032_bib14","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0889-8553(05)70252-1","article-title":"Cyclooxygenase-2 inhibitors: a new class of anti-inflammatory agents that spare the gastrointestinal tract","volume":"25","author":"Masferrer","year":"1996","journal-title":"Gastroenterol Clin N Am"},{"key":"10.1016\/j.jhep.2005.02.032_bib15","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/ijc.2910400512","article-title":"Alternative methods of selecting rat hepatocellular nodules resistant to 2-acetylaminofluorene","volume":"40","author":"Semple-Roberts","year":"1987","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jhep.2005.02.032_bib16","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1177\/17.8.517","article-title":"Histochemical and ultrastructural demonstration \u03b3-glutamil transpeptidase activity","volume":"17","author":"Rutenburg","year":"1969","journal-title":"J Histochem Citochem"},{"key":"10.1016\/j.jhep.2005.02.032_bib17","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/0006-2952(90)90467-Y","article-title":"7-Alkoxyquinolines: new fluorescent substrates for cytochrome P450 monooxygenases","volume":"40","author":"Mayer","year":"1990","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jhep.2005.02.032_bib18","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1126\/science.154.3757.1662","article-title":"Nuclei from rat liver: isolation method that combines purity with high yield","volume":"154","author":"Blobel","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.jhep.2005.02.032_bib19","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/0076-6879(74)31005-1","article-title":"Subcellular fractionation of rat liver","volume":"31","author":"Fleischer","year":"1974","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.jhep.2005.02.032_bib20","first-page":"293","article-title":"Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis","volume":"60","author":"Reddy","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.jhep.2005.02.032_bib21","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/BF00052847","article-title":"Enzymes of glutathione metabolism as biochemical markers during hepatocarcinogenesis","volume":"6","author":"Hendrich","year":"1987","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.jhep.2005.02.032_bib22","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3109\/10409239209082566","article-title":"Glutathione transferases and cancer","volume":"27","author":"Tsuchida","year":"1992","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"10.1016\/j.jhep.2005.02.032_bib23","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/sj.onc.1200886","article-title":"PCNA: structure, functions and interactions","volume":"14","author":"Kelman","year":"1997","journal-title":"Oncogene"},{"key":"10.1016\/j.jhep.2005.02.032_bib24","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9","article-title":"The Ki-67 protein: from the known and the unknown","volume":"182","author":"Scholzen","year":"2000","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.jhep.2005.02.032_bib25","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/j.1749-6632.2002.tb04671.x","article-title":"Chemopreventive agents induce suppression of nuclear factor-kappaB leading to chemosensitization","volume":"973","author":"Bharti","year":"2002","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.jhep.2005.02.032_bib26","first-page":"415","article-title":"Beta-carotene inhibits persistent and stimulates remodeling gamma GT-positive preneoplastic lesions during early promotion of hepatocarcinogenesis","volume":"67","author":"Rizzi","year":"1997","journal-title":"Int J Vitam Nutr Res"},{"key":"10.1016\/j.jhep.2005.02.032_bib27","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/ijc.11595","article-title":"Chemoprotective effect of caffeic acid phenethyl ester on promotion in a medium-term rat hepatocarcinogenesis assay","volume":"108","author":"Carrasco-Legleu","year":"2004","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jhep.2005.02.032_bib28","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1096\/fj.01-0299fje","article-title":"COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib","volume":"15","author":"Grosch","year":"2001","journal-title":"FASEB J"},{"key":"10.1016\/j.jhep.2005.02.032_bib29","first-page":"6045","article-title":"Celecoxib prevents tumor growth in vivo without toxicity to normal gut: lack of correlation between in vitro and in vivo models","volume":"60","author":"Williams","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.jhep.2005.02.032_bib30","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/ijc.10409","article-title":"NS-398, a selective cyclooxygenase 2 inhibitor, inhibited cell growth and induced cell cycle arrest in human hepatocellular carcinoma cell lines","volume":"99","author":"Cheng","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jhep.2005.02.032_bib31","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1023\/A:1020224503335","article-title":"Cyclooxygenase inhibitors block cell growth, increase ceramide and inhibit cell cycle","volume":"76","author":"Kundu","year":"2002","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.jhep.2005.02.032_bib32","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.jhep.2004.02.016","article-title":"Simultaneous abrogation of NOS-2 and COX-2 activities is lethal in partially hepatectomised mice","volume":"40","author":"Zeini","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2005.02.032_bib33","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1093\/carcin\/bgh151","article-title":"Chemopreventive activity of parthenolide against UVB-induced skin cancer and its mechanisms","volume":"25","author":"Won","year":"2004","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.jhep.2005.02.032_bib34","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S1359-6101(00)00018-6","article-title":"NF-kappaB and cell-cycle regulation: the cyclin connection","volume":"12","author":"Joyce","year":"2001","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.jhep.2005.02.032_bib35","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1053\/jhep.2001.24024","article-title":"Involvement of p21(WAF1\/Cip1), p27(Kip1), and p18(INK4c) in troglitazoneinduced cell-cycle arrest in human hepatoma cell lines","volume":"33","author":"Koga","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2005.02.032_bib36","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0168-8278(04)90021-9","article-title":"The selective cyclooxygenase-2 inhibitor SC-236 reduces experimental liver fibrosis by inactivating kupffer cells and acting as a peroxisome proliferator-activated receptor gamma ligand","volume":"40","author":"Planagum\u00e0","year":"2004","journal-title":"J Hepatol"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827805002667?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827805002667?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,18]],"date-time":"2019-02-18T09:50:54Z","timestamp":1550483454000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827805002667"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["S0168827805002667"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2005.02.032","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2005,10]]}}}